[1]Patent:WO2011/117254,2011,A1
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
102308-48-5
116797-02-5
1193-03-9
1197229-33-6
120088-53-1
127285-08-9
91041-21-3 | METHYL 3-(2-AMINOPHENOXY)-2-THIOPHENECARBOXYLATE | AA00GSWX | MFCD04117806
864445-60-3 | 2-(2-BroMophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone | AA00GT8F
902120-00-7 | 3-(t-Butyldimethylsilyloxy)phenylboronic acid, pinacol ester | AA00GTBT | MFCD04039307
879996-77-7 | 3-(3,4-Dimethoxyphenyl)-1h-pyrazole-4-carboxylic acid | AA00GTIV | MFCD06809632
915924-93-5 | 6-Oxo-1-propylpiperidine-3-carboxylic acid | AA00GTNL | MFCD08691592
87553-74-0 | H-D-Tyr-OtBu | AA00GTRT | MFCD00191035
887401-93-6 | INCB 3284 diMesylate | AA00GU0Y | MFCD20926352
893422-47-4 | Akt1 and Akt2-IN-1 | AA00GU56 | MFCD13184803
929974-17-4 | 4-Fluoro-3-(phenoxymethyl)benzo[b]thiophene-2-carboxylic acid | AA00GU99 | MFCD08729207
923176-95-8 | 2-(Ethylsulfonamido)acetic acid | AA00GUD6 | MFCD08444876